4
Changes in Ownership
Immunome Inc. Filed Acc 0001994071-26-000004
Chief Financial Officer sold 60,000 shares at $18.23 ($1,093,800)
- Chief Financial Officer acquired 60,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Rosett Max · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +60,000 | $1.05 | $63,000 | 114,037 | D |
| 2026-06-15 | Sale : show line 2 in the form 10b5-1 | −60,000 | $18.23 | $1,093,800 | 54,037 | D |
| Open-market sales · 60,000 sh · avg $18.23 · $1,093,800 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-15 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | −60,000 | 0 | D |
Loading xslF345X06/form4-06172026_090615.xml…